Company AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. 11:35:21 2024-02-29 am EST 5-day change 1st Jan Change
9,983 GBX -1.94% Intraday chart for AstraZeneca PLC -1.18% -5.82%

Business Summary

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:

- product sales (96.9%). Net sales break down by treatment area between oncology (34%), cardiovascular, renal and metabolic diseases (21.4%), respiratory and autoimmune diseases (13.4%), and other (31.2%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);

- collaboration revenue (3.1%).

Net sales are distributed geographically as follows: the United Kingdom (7%), Europe (20.1%), Americas (44.2%) and Africa/Asia/Australia (28.7%).

Number of employees: 89,900

Sales per Business

GBP in Million2022Weight2023Weight Delta
Oncology
37.4 %
11,878 33.0 % 13,793 37.4 % +16.12%
Cardiovascular, Renal and Metabolism
23.1 %
7,459 20.7 % 8,515 23.1 % +14.16%
Rare Disease
16.9 %
5,726 15.9 % 6,246 16.9 % +9.08%
Respiratory and Immunology
13.3 %
4,680 13.0 % 4,913 13.3 % +4.97%
Alliance
3.1 %
- - 1,149 3.1 % -
Other Medicines
2.6 %
1,319 3.7 % 946 2.6 % -28.29%
Vaccines and Immune Therapies
2.2 %
3,845 10.7 % 814 2.2 % -78.83%
Collaboration
1.3 %
1,098 3.1 % 478 1.3 % -56.50%

Sales per region

GBP in Million2022Weight2023Weight Delta
United States
39.6 %
14,027 39.0 % 14,578 39.6 % +3.93%
China
12.8 %
4,662 12.9 % 4,724 12.8 % +1.32%
Japan
7.9 %
3,236 9.0 % 2,928 7.9 % -9.51%
United Kingdom
7.4 %
2,530 7.0 % 2,709 7.4 % +7.07%
Other Rest of Europe
6.8 %
2,197 6.1 % 2,502 6.8 % +13.89%
Germany
4.6 %
1,544 4.3 % 1,689 4.6 % +9.36%
Other Asia, Africa and Australasia
4.5 %
1,953 5.4 % 1,645 4.5 % -15.77%
Sweden
3.7 %
1,397 3.9 % 1,371 3.7 % -1.89%
Other Americas
3.7 %
954 2.6 % 1,354 3.7 % +41.94%
France
2.5 %
899 2.5 % 927 2.5 % +3.12%
Canada
2.1 %
947 2.6 % 778 2.1 % -17.82%
Spain
1.8 %
599 1.7 % 681 1.8 % +13.73%
Italy
1.8 %
597 1.7 % 654 1.8 % +9.61%
Australia
0.9 %
464 1.3 % 314 0.9 % -32.32%

Managers

Managers TitleAgeSince
Chief Executive Officer 63 12-09-30
Director of Finance/CFO 50 21-07-31
Chief Tech/Sci/R&D Officer 56 19-12-31
Chief Tech/Sci/R&D Officer - 23-07-31
Chief Tech/Sci/R&D Officer 60 -
Chief Tech/Sci/R&D Officer - 23-05-17
Chief Operating Officer 53 15-05-31
Compliance Officer - 94-12-31
Corporate Officer/Principal 62 01-12-31
Corporate Officer/Principal - 00-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 65 17-09-30
Corporate Officer/Principal 59 13-01-31
Director/Board Member 63 17-04-26
Director/Board Member 68 99-03-31
Corporate Officer/Principal 71 13-05-31
Director/Board Member 66 21-07-31
Chairman 67 19-08-31
Chief Executive Officer 63 12-09-30
Director/Board Member 64 17-11-30
Director of Finance/CFO 50 21-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,550,189,338 1,495,368,837 ( 96.46 %) 0 96.46 %

Shareholders

NameEquities%Valuation
BlackRock Investment Management (UK) Ltd.
4.420 %
68,512,693 4.420 % 9 161 M p
Wellington Management Co. LLP
4.201 %
65,120,892 4.201 % 8 707 M p
The Vanguard Group, Inc.
3.511 %
54,425,000 3.511 % 7 277 M p
Investor AB (Investment Company)
3.328 %
51,587,810 3.328 % 6 898 M p
BlackRock Fund Advisors
1.888 %
29,273,465 1.888 % 3 914 M p
BlackRock Advisors (UK) Ltd.
1.392 %
21,573,523 1.392 % 2 885 M p
GQG Partners LLC
1.137 %
17,620,000 1.137 % 2 356 M p
Swedbank Robur Fonder AB
1.112 %
17,233,067 1.112 % 2 304 M p
SSgA Funds Management, Inc.
0.9784 %
15,167,101 0.9784 % 2 028 M p
BlackRock Advisors LLC
0.9629 %
14,926,092 0.9629 % 1 996 M p
NameEquities%Valuation
T. Rowe Price International Ltd.
1.686 %
52,269,524 1.686 % 3 483 M p
Wellington Management Co. LLP
1.595 %
49,444,180 1.595 % 3 295 M p
PRIMECAP Management Co.
1.387 %
42,987,075 1.387 % 2 865 M p
Capital Research & Management Co. (International Investors)
1.122 %
34,782,762 1.122 % 2 318 M p
Fidelity Management & Research Co. LLC
0.6877 %
21,321,999 0.6877 % 1 421 M p
Jennison Associates LLC
0.5720 %
17,732,542 0.5720 % 1 182 M p
Sanders Capital LLC
0.4736 %
14,684,066 0.4736 % 979 M p
GQG Partners LLC
0.4470 %
13,858,383 0.4470 % 924 M p
Eaton Vance Management
0.4042 %
12,530,160 0.4042 % 835 M p
Merrill Lynch International
0.3772 %
11,695,224 0.3772 % 779 M p
NameEquities%Valuation
Caixa DTVM SA
0.003157 %
293,783 0.003157 % 3 M p

Holdings

NameEquities%Valuation
18,750,000 75.00% 1,498,543,688 $
32,100,518 9.06% 907,184,714 $
71,059,999 16.88% 54,476,016 $
16,000,000 22.30% 46,960,800 $
7,485,500 9.26% 20,083,896 $
4,011,215 4.97% 12,514,991 $
3,584,230 3.63% 663,083 $
884,956 1.99% 61,947 $

Company contact information

AstraZeneca PLC

Cambridge Biomedical Campus 1 Francis Crick Avenue

CB2 0AA, Cambridge

+44 20 3749 5000

http://www.astrazeneca.co.uk
address AstraZeneca PLC(AZN)

Group companies

NameCategory and Sector
Miscellaneous Commercial Services
Pharmaceuticals: Major
Miscellaneous Commercial Services
Insurance Brokers/Services
Pharmaceuticals: Major
Astrazeneca Holdings BV
Miscellaneous Commercial Services
Miscellaneous Commercial Services
Astrazeneca Treasury BV

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
128.8 USD
Average target price
162.2 USD
Spread / Average Target
+25.89%
Consensus
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW